Mounjaro KwikPen 5MG/0.6ML SC Pre-Filled Pen 1s

Mounjaro KwikPen contains an active substance called tirzepatide and is used to treat adults with type 2 diabetes mellitus. Mounjaro reduces the level of sugar in the body only when the levels of sugar are high.Mounjaro is also used to treat adults with obesity or overweight (with BMI of at least 27 kg/m2 ). Mounjaro influences appetite regulation, which may help you eat less food and reduce your body weight.

In Type 2 Diabetes, Mounjaro Is Used :

• On its own when you can’t take metformin (another diabetes medicine)
• With other medicines for diabetes when they are not enough to control your blood sugar levels. These other medicines may be medicines taken by mouth and/or insulin given by injection.

Mounjaro is also used together with diet and exercise for weight loss and to help keep the weight under control in adults, who have :

• a BMI of 30 kg/m² or greater (obesity) or
• a BMI of at least 27 kg/m² but less than 30 kg/m² (overweight) and weight-related health problems (such as prediabetes, type 2 diabetes, high blood pressure, abnormal levels of fats in the blood, breathing problems during sleep called ‘obstructive sleep apnoea’ or a history of heart attack, stroke or blood vessel problems)

BMI (Body Mass Index) is a measure of your weight in relation to your height.

It is important to continue to follow the advice on diet and exercise given to you by your doctor, nurse or pharmacist.

Do not use Mounjaro KwikPen : If you are allergic to tirzepatide or any of the other ingredients of this medicine.

• Children and adolescents : This medicine should not be given to children and adolescents under 18 years of age because it has not been studied in this age group.
• Other medicines and Mounjaro : Tell your doctor, nurse or pharmacist if you are using, have recently used or might use any other medicines.
• Pregnancy : If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine. This medicine should not be used during pregnancy as the effects of this medicine on an unborn child are not known. Therefore, it is recommended to use contraception while using this medicine.
• Breast-feeding : It is unknown whether tirzepatide passes into breast milk. A risk to newborns/infants cannot be ruled out. If you are breast-feeding or are planning to breast-feed, talk to your doctor before using this medicine. You and your doctor should decide if you should stop breast-feeding or delay using Mounjaro.
• Driving and using machines : It is unlikely that this medicine will affect your ability to drive and use machines. However, if you use Mounjaro in combination with a sulphonylurea or insulin, low blood sugar (hypoglycaemia) may occur which may reduce your ability to concentrate. Avoid driving or using machines if you get any signs of low blood sugar, e.g. headache, drowsiness, weakness, dizziness, feeling hungry, confusion, irritability, fast heartbeat and sweating (see section 4). See section 2, ‘Warnings and precautions’ for information on increased risk of low blood sugar. Talk to your doctor for further information.
• Mounjaro KwikPen contains sodium : This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium-free.

How to use : Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure how to use this medicine.

• The starting dose is 2.5 mg once a week for four weeks. After four weeks your doctor will increase your dose to 5 mg once a week.
• Your doctor may increase your dose by 2.5 mg increments to 7.5 mg, 10 mg, 12.5 mg or 15 mg once a week if you need it. In each case your doctor will tell you to stay on a particular dose for at least 4 weeks before going to a higher dose.
• Do not change your dose unless your doctor has told you to.

Choosing when to use Mounjaro : You can use your pen at any time of the day, with or without meals. You should use it on the same day each week if you can. To help you remember, when to use Mounjaro, you may wish to mark it on a calendar.

If necessary, you can change the day of your weekly Mounjaro injection, as long as it has been at least 3 days since your last injection. After selecting a new dosing day, continue with once-a-week dosing on that new day.

How to inject Mounjaro KwikPen : Mounjaro is injected under the skin (subcutaneous injection) of your stomach area (abdomen) or upper leg (thigh) or upper arm. You may need help from someone else if you want to inject in your upper arm.

If you want to do so, you can use the same area of your body each week. But be sure to choose a different injection site within that area. If you also inject insulin choose a different injection site for that injection.

Ingredients : : One ml of solution contains 8.33 mg of tirzepatide. Each multi-use pre-filled pen contains 4 doses of 5 mg.